BRPI0518359A2 - antagonistas de gaba-esteràide e seu uso para tratamento de distérbios do snc - Google Patents
antagonistas de gaba-esteràide e seu uso para tratamento de distérbios do sncInfo
- Publication number
- BRPI0518359A2 BRPI0518359A2 BRPI0518359-6A BRPI0518359A BRPI0518359A2 BR PI0518359 A2 BRPI0518359 A2 BR PI0518359A2 BR PI0518359 A BRPI0518359 A BR PI0518359A BR PI0518359 A2 BRPI0518359 A2 BR PI0518359A2
- Authority
- BR
- Brazil
- Prior art keywords
- gaba
- treatment
- receptor
- steroid
- antagonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62951104P | 2004-11-18 | 2004-11-18 | |
| PCT/SE2005/001671 WO2006054938A1 (en) | 2004-11-18 | 2005-11-07 | Gaba-steroid antagonists and their use for the treatment of cns disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0518359A2 true BRPI0518359A2 (pt) | 2008-11-18 |
Family
ID=36407411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0518359-6A BRPI0518359A2 (pt) | 2004-11-18 | 2005-11-07 | antagonistas de gaba-esteràide e seu uso para tratamento de distérbios do snc |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8114860B2 (enExample) |
| EP (1) | EP1812009B1 (enExample) |
| JP (1) | JP4914368B2 (enExample) |
| CN (1) | CN101076340B (enExample) |
| AU (1) | AU2005307151B2 (enExample) |
| BR (1) | BRPI0518359A2 (enExample) |
| CA (1) | CA2585359C (enExample) |
| DK (1) | DK1812009T3 (enExample) |
| ES (1) | ES2423493T3 (enExample) |
| MX (1) | MX2007006032A (enExample) |
| WO (1) | WO2006054938A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1812009T3 (da) | 2004-11-18 | 2013-08-05 | Umecrine Ab | GABA-steroidantagonister og deres anvendelse til behandling af CNS-lidelser |
| EP2711372A1 (en) | 2006-11-21 | 2014-03-26 | Umecrine AB | The use of pregnane and androstane steroids for the manufacture of a pharmaceutical composition for the treatment of CNS disorders |
| CN101585862B (zh) * | 2008-05-20 | 2014-12-17 | 梅克芳股份公司 | 甾族化合物 |
| US20110086828A1 (en) * | 2009-10-07 | 2011-04-14 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Treatment of alcohol abuse and alcoholism using modulators of neurosteroid binding sites on gabaa receptors |
| JP5687287B2 (ja) | 2010-01-14 | 2015-03-18 | ウメクライン ムード エービー | 改善された保存性及び溶解特性を有する３−ベータ−ヒドロキシ−５−アルファ−プレグナン−２０−オンを含有する薬学的組成物 |
| BE1030177B1 (nl) | 2022-02-04 | 2024-01-15 | Rousselot Bv | Gebruik van collageen hydrolysaat bij de preventie en/of behandeling van selectieve honger |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4614499A (en) * | 1985-04-29 | 1986-09-30 | Universite Laval | Simulator for use as a neurosurgical aid in determining potential paths for the implantation of probes through the human body |
| CN1270718C (zh) | 1998-03-11 | 2006-08-23 | 托布乔恩·贝克斯托罗姆 | 表别孕烷醇酮在制备治疗甾族化合物诱导的疾病的药物中的应用 |
| FR2806303B1 (fr) | 2000-03-17 | 2002-09-27 | Inst Nat Sante Rech Med | Composes capables de se lier a des proteines constituantes ou associees aux elements du cytosquelette et leurs applications pour la fabrication de medicaments |
| US20030125311A1 (en) * | 2000-03-17 | 2003-07-03 | Etienne-Emile Baulieu | Compounds capable of binding with the cytoskeleton |
| SE0104423D0 (sv) * | 2001-12-27 | 2001-12-27 | Umecrine Ab | Pregnane steroids and their use in the treatment of CNS disorders |
| DK1812009T3 (da) | 2004-11-18 | 2013-08-05 | Umecrine Ab | GABA-steroidantagonister og deres anvendelse til behandling af CNS-lidelser |
-
2005
- 2005-11-07 DK DK05801885.4T patent/DK1812009T3/da active
- 2005-11-07 AU AU2005307151A patent/AU2005307151B2/en not_active Ceased
- 2005-11-07 ES ES05801885T patent/ES2423493T3/es not_active Expired - Lifetime
- 2005-11-07 WO PCT/SE2005/001671 patent/WO2006054938A1/en not_active Ceased
- 2005-11-07 CA CA2585359A patent/CA2585359C/en not_active Expired - Fee Related
- 2005-11-07 JP JP2007542970A patent/JP4914368B2/ja not_active Expired - Fee Related
- 2005-11-07 MX MX2007006032A patent/MX2007006032A/es active IP Right Grant
- 2005-11-07 EP EP05801885.4A patent/EP1812009B1/en not_active Expired - Lifetime
- 2005-11-07 US US11/791,160 patent/US8114860B2/en not_active Expired - Fee Related
- 2005-11-07 BR BRPI0518359-6A patent/BRPI0518359A2/pt not_active IP Right Cessation
- 2005-11-07 CN CN2005800394888A patent/CN101076340B/zh not_active Expired - Fee Related
-
2012
- 2012-02-13 US US13/372,389 patent/US8372824B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005307151B2 (en) | 2011-10-20 |
| ES2423493T3 (es) | 2013-09-20 |
| US20080070876A1 (en) | 2008-03-20 |
| WO2006054938A1 (en) | 2006-05-26 |
| EP1812009B1 (en) | 2013-05-15 |
| MX2007006032A (es) | 2007-10-17 |
| CA2585359A1 (en) | 2006-05-26 |
| CN101076340A (zh) | 2007-11-21 |
| JP2008525317A (ja) | 2008-07-17 |
| AU2005307151A1 (en) | 2006-05-26 |
| EP1812009A4 (en) | 2010-08-11 |
| US8114860B2 (en) | 2012-02-14 |
| CN101076340B (zh) | 2011-01-12 |
| EP1812009A1 (en) | 2007-08-01 |
| JP4914368B2 (ja) | 2012-04-11 |
| US20120142657A1 (en) | 2012-06-07 |
| DK1812009T3 (da) | 2013-08-05 |
| US8372824B2 (en) | 2013-02-12 |
| CA2585359C (en) | 2013-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200970542A1 (ru) | ИНГИБИТОРЫ ДЕЙСТВИЯ Akt | |
| GB0625648D0 (en) | Compounds | |
| BRPI0720270B8 (pt) | compostos 4-fenil-6-(2,2,2-triflúor-1-fenil etoxi) pirimidina, composição e forma de dosagem sólida | |
| ECSP067076A (es) | Derivados de pirimidina urea como inhibidores de la quinasa | |
| BRPI0715893A2 (pt) | composto de azetidina e uso para a preparaÇço de um medicamento para a prevenÇço ou tratamento de distérbios distÍmicos ou do sono | |
| MA32393B1 (fr) | Composés et compositions servant d'inhibiteurs de kinases | |
| WO2006135627A3 (en) | Inhibitors of akt activity | |
| EA201000341A1 (ru) | 2-анилинопурин-8-оны в качестве ингибиторов ttk/mps1 для лечения пролиферативных нарушений | |
| EA200901486A1 (ru) | СОЕДИНЕНИЯ И КОМПОЗИЦИИ, КАК ИНГИБИТОРЫ КИНАЗЫ c-KIT И PDGFR | |
| EP2512479A4 (en) | METHOD AND COMPOSITIONS FOR TREATING PERIPHERAL VASCULAR DISEASE | |
| PT2222669E (pt) | Derivados de oxadiazole ativos em esfingosina-1-fosfato (s1p) | |
| MX2009007944A (es) | Compuestos y composiciones de purina como inhibidores de quinasa para el tratamiento de enfermedades relacionadas con plasmodium. | |
| MA33803B1 (fr) | Inhibiteur de bromodomaine de benzodiazépine | |
| EP2350129A4 (en) | PD1 Antagonist Compositions and Methods for their Use | |
| MX2011008171A (es) | Composicion farmaceutica que comprende linagliptina y opcionalmente un inhibidor de sglt2, y usos de la misma. | |
| MX2010002732A (es) | Inhibidores de f1f0-atpasa y metodos relacionados. | |
| WO2010042925A3 (en) | Compositions and methods for treating alcohol use disorders, pain and other diseases | |
| MX2009010127A (es) | Compuestos utiles como inhibidores de janus cinasas. | |
| CL2011002925A1 (es) | Compuestos derivados de isoquinolin-1(2h)-ona, inhibidores selectivos de la actividad de poli (adp-ribosa) polimerasa parp-1; proceso para prepararlos; composicion farmaceutica; y su uso para tratar una enfermedad mediada por la proteina parp-1. | |
| WO2009082038A3 (en) | Ampa receptor antagonists and zonisamide for epilepsy | |
| EA200901484A1 (ru) | СОЕДИНЕНИЯ И КОМПОЗИЦИИ КАК ИНГИБИТОРЫ КИНАЗЫ c-KIT И PDGFR | |
| WO2008049842A3 (en) | Egfr kinase inhibitor combinations for the treatment of respiratory and gastrointestinal disorders | |
| WO2008043052A3 (en) | Human antibodies neutralizing human metapneumovirus | |
| WO2008097924A3 (en) | Pharmaceutical compositions comprising dextromethorphan analogs for the treatment of neurological disorders | |
| TNSN07263A1 (en) | Substituted 4-phenyl tetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 13A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2487 DE 04-09-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |